SCHEMBL27816573

SCHEMBL27816573

CN(C)N=Nc1cccc(-c2ccc(C(N)=O)s2)c1

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 1/20 0.52
▸ IKBKB O14920 1/20 0.47
▸ HSD17B2 P37059 12/20 0.43
▸ HSD17B1 P14061 11/20 0.43
▸ HPGDS O60760 2/20 0.42
▸ RAB9A P51151 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27816545 0.88 HPGDS (0.56) HSD17B2HSD17B1HPGDSRAB9AKDM4E
SCHEMBL5605082 0.77 HSD17B1 (0.60) EPHX2IKBKBHSD17B2HSD17B1HPGDS
SCHEMBL2690201 0.74 IKBKB (0.68) EPHX2IKBKBHPGDSRAB9AKDM4E
SCHEMBL1784584 0.73 HPGDS (0.73) EPHX2IKBKBHSD17B2HSD17B1HPGDS
SCHEMBL6612574 0.73 HPGDS (0.60) EPHX2IKBKBHSD17B2HSD17B1HPGDS
SCHEMBL28911367 0.73 PARP1 (0.49) RAB9AKDM4ENPC1ALDH1A1MEN1
SCHEMBL29922717 0.72 EPHX2 (0.58) EPHX2IKBKBHSD17B2HSD17B1HPGDS
SCHEMBL28541614 0.72 EPHX2 (0.58) EPHX2IKBKBHSD17B2HSD17B1HPGDS
SCHEMBL27565420 0.72 ESRRG (0.59) EPHX2IKBKBHSD17B2HSD17B1HPGDS
SCHEMBL27565581 0.72 IKBKB (0.71) EPHX2IKBKBHSD17B2HSD17B1HPGDS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102149703-A Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers LAILA NUTRACEUTICALS 2011-08-10 — — CN claimed
CN-102149703-B Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers LAILA NUTRACEUTICALS 2014-09-10 — — CN disclosed
CN-102149703-A Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers LAILA NUTRACEUTICALS 2011-08-10 — — CN disclosed
Send feedback